I think you can use google search and AI as well as me. Ava6000 is approaching the window. Probably during P2. I think you must agree it not bring fast tracked yet is a poor effort at spreading fud.
Very very few drugs get fast tracked in P1a and early P1 b. That’s it end of that conversation. Anyone trying to make anymore of it is being snide or misleading.
No D Geeman. THE royalty deal. Why else is David Bryant on the board? It could land between now and ESMO. It might not materialise at all. But with Bryant on board and his connections with Healthcare royalty, I think we can confidently talk about THE royalty deal.
Your coverage and ‘getting it right’ is more monkey’s and typewriters than accurate commentary. Honestly thousands of posts, vast majority incorrect’concerns’. But as I said, great to see you’ve seen the light. Tom the bomb mrk2..
But I didn’t compare it to a bankrupt company or bang on about irrelevant half life issues, you called it wrong so often it’s unreal. Glad you’ve seen the light now and are now board.
Touk, you are name calling when you call others Pom Pom girls. Eggy, you’re now a Pom Pom girl, if D Geeman wants to join in they’ll have to hop over the fence and join in.
I just don’t think the low point of any company is relevant to a takeover price. It doesn’t take into account any developments which in themselves change the total outlook and proposition. So I’ll double down on what I previously said and say it has no bearing.